Financial results - BIOTEK SINERGO SRL

Financial Summary - Biotek Sinergo Srl
Unique identification code: 37548640
Registration number: J02/800/2017
Nace: 2399
Sales - Ron
59.083
Net Profit - Ron
20.513
Employee
The most important financial indicators for the company Biotek Sinergo Srl - Unique Identification Number 37548640: sales in 2023 was 59.083 euro, registering a net profit of 20.513 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Fabricarea altor produse din minerale nemetalice, n.c.a. having the NACE code 2399.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Biotek Sinergo Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 219 21.241 14.557 1.500 16.767 56.070 59.083
Total Income - EUR - - - 219 21.324 14.630 1.608 16.806 56.169 60.368
Total Expenses - EUR - - - 115 16.355 15.265 8.308 30.187 47.721 36.560
Gross Profit/Loss - EUR - - - 104 4.970 -635 -6.700 -13.381 8.448 23.808
Net Profit/Loss - EUR - - - 98 4.331 -1.073 -6.746 -13.885 6.755 20.513
Employees - - - 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 5.7%, from 56.070 euro in the year 2022, to 59.083 euro in 2023. The Net Profit increased by 13.778 euro, from 6.755 euro in 2022, to 20.513 in the last year.

Check the financial reports for the company - Biotek Sinergo Srl

Rating financiar

Financial Rating -
Biotek Sinergo Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Biotek Sinergo Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biotek Sinergo Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Biotek Sinergo Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biotek Sinergo Srl - CUI 37548640

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 0 1.053 1.722 1.780 2.586 2.177 6.182
Current Assets - - - 148 3.800 2.638 10.625 20.699 71.401 41.386
Inventories - - - 0 0 0 0 0 0 0
Receivables - - - 0 0 1.894 10.579 17.095 58.925 40.628
Cash - - - 148 3.800 744 45 3.604 12.476 758
Shareholders Funds - - - 141 4.469 3.309 -3.500 -17.307 -10.606 9.944
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 7 472 1.058 8.183 40.970 84.184 28.782
Income in Advance - - - 0 0 0 7.721 0 0 8.843
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "2399 - 2399"
CAEN Financial Year 2399
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 41.386 euro in 2023 which includes Inventories of 0 euro, Receivables of 40.628 euro and cash availability of 758 euro.
The company's Equity was valued at 9.944 euro, while total Liabilities amounted to 28.782 euro. Equity increased by 20.518 euro, from -10.606 euro in 2022, to 9.944 in 2023. The Debt Ratio was 60.5% in the year 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Biotek Sinergo Srl

Comments - Biotek Sinergo Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.